Introduction and aim Method Conclusions 6 Case Report Summary Results Discussion
Page 1 RCPysch2022 Presented at: T. TEODORO1,2, V. NOGUEIRA3, M. TELES …

Clozapine is a second-generation antipsychotic shown to benefit patients with treatment-
resistant psychosis. 1 Recent reports suggest off-label use of clozapine may help treat …

Discussion. It seemsunlikelythat these reactions were relatedto the residual effectsof the
patient's previousantipsychotic drugs. The oral medications had been discontinued 9 days …

Background and purpose: Oculogyric crisis which is a dystonic reaction commonly caused
by typical antipsychotics treatment of acute dystonias, rarely occurs with atypical …

Background Clozapine is a novel antipsychotic that is effective in 30% to 50% of treatment-
resistant schizophrenia. It is known to cause sialorrhea in 23% of patients. This …

Case presentation Mr. S is a 32-year-old male with schizophrenia. Due to poor responses to
various antipsychotic medications, he was started on clozapine with the dose titrated to 300 …

Clozapine is an atypical antipsychotic which is generally used as a second line
antipsychotic drug in clinical practice due to its side effects. It is known that Clozapine may …

Discussion We report the case of a patient who developed a parotitis following clozapine
dose adjustment. Clozapine induced parotitis was retained once the infectious and other …

Ceftriaxone is a third generation cephalosporin antibiotic, used commonly due to their broad
spectrum of activity. As the therapeutic use of cephalosporin are increasing, reports of …

The man, who had chronic paranoid schizophrenia and had previously received
fluphenazine, was admitted due to severe psychotic symptoms. At the time of admission, he …